New diabetic drugs: a summary
Keywords: new diabetic drugs
AbstractInsulin is used in both type 1 and brittle type 2 diabetics. Traditionally insulin has been administered with multiple daily injections (MDI) and patients had to self monitor their blood glucose (SMBG) by needlestick.
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.